Starling Oncology, Inc. Common Stock (STLN) is a publicly traded the market company. As of October 1, 2026, STLN trades at $6.22 with a market cap of $663.47M and a P/E ratio of 0.00. STLN moved -1.11% today. Year to date, STLN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $4.85 to $7.13. Analyst consensus is strong buy with an average price target of $9.25. Rallies surfaces STLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Starling Oncology, Inc. Common Stock (STLN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. STLN moved -1.11% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.22 |
| Market Cap | $663.47M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.13 |
| 52-Week Low | $4.85 |
| Volume | 843.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover STLN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.25.